Canadian Cardiovascular Society

CCS Research Fellowships & Awards

CCS-Bayer Cardiovascular Research Award

The CCS − Bayer Cardiovascular Research Award is open to Canadian clinical trainees (PGY 4-6) undertaking a research project on any topic related to thrombosis, anticoagulation, stroke, heart failure, atrial fibrillation, or cardiac imaging — particularly research that has the potential to advance knowledge about or improve the care of patients at risk for vascular, thrombotic or embolic events.

DEADLINE EXTENDED
2022 Call for Applications: Closes July 27th, 2022 at 11:59 a.m. EDT


CCS/HSRLCE/BI-Lilly Cardiometabolic Research Award

The Canadian Cardiovascular Society (CCS), Heart & Stroke / Richard Lewar Centre of Excellence in Cardiovascular Research (HSRLCE), and the BI-Lilly Alliance are proud to support the 2022 CCS/HSRLCE/BI-Lilly Cardiometabolic Research Award. This award is intended for early career members for a research project on any topic related to cardiometabolic disease.

DEADLINE EXTENDED
2022 Call for Applications: Closes July 27th, 2022 at 11:59 a.m. EDT


CCS-HLS Atherosclerosis Research Award

The Canadian Cardiovascular Society and HLS Therapeutics are proud to support the 2022 CCS/HLS Atherosclerosis Research Award. Open to Canadian MDs in the first 5 years of their first clinical appointment in an academic department for a research project on the topic of atherosclerosis. Priority will be given to research that has the potential to advance clinical knowledge of atherosclerosis process linked to inflammation, membrane stability and biomarkers.

DEADLINE EXTENDED
2022 Call for Applications: Closes July 27th, 2022 at 11:59 a.m. EDT


NEW! CCS-BMS Hypertrophic Cardiomyopathy (HCM) Research Award

The Canadian Cardiovascular Society and Bristol Myers Squibb (BMS) are proud to support the CCS-BMS Hypertrophic Cardiomyopathy (HCM) Research Award. The purpose of this award is to foster growth of peer-reviewed Canadian research in the area of HCM, with a focus on HCM diagnosis, progression monitoring, epidemiology and/or prevalence.

2022 Call for Applications: Closed


CCS/Pfizer ATTR-CM Research Fellowship Award

This is a salary award where the purpose is to foster the growth of peer-reviewed Canadian research in the area of Transthyretin Amyloid Cardiomyopathy (ATTR-CM), with a focus on excellence and support for early career Canadian researchers familiar with diagnosing and treating patients with ATTR-CM who are looking to establish an independent research career.

2022 Call for Applications: Closed


BMS-Pfizer AF Research Award

Sponsored by the BMS-Pfizer alliance, the AF (Atrial Fibrillation) Research Awards support excellence in AF research and support promising Canadian early career researchers with an interest in AF.

2021 Call for Applications: Closed


CCS COVID-19 Challenge for Canada Initiative (CCS-C3I)

As the prevalence and outcomes of cardiovascular complications of COVID-19 remain poorly understood and uncharacterized, the aim of C3I  is to empower the CCS clinician-scientist community to be prepared to harness emerging large-scale funds. By fostering multisite cardiovascular research across Canada, our CV community will be at the forefront of readiness for large-scale, CVD-related COVID-19 disease initiatives.

2021 Call for Applications: Closed


For more information on developing a customized research fellowship or award with the CCS, please reach out to researchawards@ccs.ca.

Back to top